42
2
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T35343 | MTI-31 | MTI-31,LXI-15029 | mTOR |
MTI-31 (LXI-15029) is a potent, orally active and highly selective inhibitor of mTORC1 and mTORC2. MTI-31 is selective for mTOR (Kd: 0.20 nM) versus PIK3CA, PIK3CB and PIK3G with >5,000 fold selectivity in mTOR binding a... | |||
T11728 | JR-AB2-011 | mTOR | |
JR-AB2-011 is a selective mTORC2 inhibitor with an IC 50 value of 0.36 μM. JR-AB2-011 inhibits mTORC2 activity by blocking Rictor-mTOR association ( K i : 0.19 μM) and is cytotoxic in glioblastoma [1]. | |||
T2475 | KU-0063794 | mTOR | |
KU-0063794 is a potent and highly specific dual-mTOR inhibitor of mTORC1 and mTORC2. | |||
T6319 | OSI-027 | ASP4786,OSI027 | DNA-PK , PI3K , mTOR , Autophagy |
OSI-027 (ASP4786) is a selective and potent dual inhibitor of mTORC1 and mTORC2 with IC50 of 22 nM and 65 nM, and more than 100-fold selectivity observed for mTOR than PI3Kα, PI3Kβ, PI3Kγ or DNA-PK. Phase 1. | |||
T6045 | Torin 1 | DNA-PK , PI3K , mTOR , Autophagy | |
Torin 1 is an effective inhibitor of mTORC1/2 with (IC50: 2 nM/10 nM); has 1000-fold selectivity for mTOR than PI3K. | |||
T9156 | CDC25B-IN-2 | Phosphatase , mTOR | |
BIA is an inhibitor of the interaction between TMBIM6 and mTORC2, which ultimately blocks AKT activation and cancer progression. | |||
T12123 | MTOR inhibitor-3 | mTOR | |
T8649 | TMBIM6 antagonist-1 | BAX-inhibitor-1,BIA | mTOR |
TMBIM6 antagonist-1 (BAX-inhibitor-1) is a bax inhibitor | |||
T36200 | AZD 3147 | mTOR | |
AZD 3147 is an inhibitor of mTORC with IC50s of 40.7 and 5.75 nM for mTORC1 and mTORC2. AZD 3147 shows IC50s of 912, 5495, 9333, and 6310 nM for PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ, respectively. | |||
T6732 | WYE-687 | p38 MAPK , PI3K , Src , mTOR | |
WYE-687 is an ATP-competitive and selective inhibitor of mTOR with IC50 of 7 nM; blocks mTORC1/pS6K(T389) and mTORC2/P-AKT(S473) but no effect observed on P-AKT(T308). Selectivity for mTOR is greater than PI3Kα (>100-fol... | |||
T14552 | Dactolisib Tosylate | BEZ235 Tosylate,NVP-BEZ 235 Tosylate | PI3K , mTOR |
Dactolisib Tosylate (BEZ235 Tosylate) is a dual kinase inhibitor that targets PI3K and mTOR. dactolisib Tosylate exhibits IC50 values of 4, 75, 7, and 5 nM for PI3Kα, β, γ, and δ, respectively. dactolisib Tosylate inhibi... | |||
T6731 | WYE-354 | Apoptosis , PI3K , mTOR , Autophagy | |
WYE-354(IC50=5 nM) is an effective, selective and ATP-competitive mTOR inhibitor. It blocks mTORC2/P-AKT(S473) and mTORC1/P-S6K(T389), not P-AKT(T308). The selectivity for mTOR is higher than PI3Kα (>100-fold) and PI3Kγ ... | |||
T6730 | WAY-600 | WAY600 | VEGFR , PI3K , Src , mTOR |
WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 nM; blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) but not P-AKT(T308); selective for mTOR than PI3Kα (>100-fold) and PI3Kγ (>500-fold... | |||
T2414 | Torkinib | PP 242 | Apoptosis , Mitophagy , PI3K , mTOR , Autophagy |
Torkinib (PP 242) (PP 242) is a selective and ATP-competitive mTOR inhibitor (IC50: 8 nM). It also inhibits mTORC1/2 (IC50s: 30/58 nM). | |||
T3514 | CZ415 | mTOR | |
CZ415 is a potent and highly selective mTOR inhibitor. | |||
T3541 | CC-115 | CC 115 | DNA-PK , PI3K , mTOR |
CC-115 is a inhibitor of mTOR/DNA-PK (IC50= 21/ 13 nM). | |||
T1961 | Vistusertib | AZD2014 | Apoptosis , Akt , PI3K , S6 Kinase , mTOR , Autophagy |
Vistusertib (AZD2014) is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity. | |||
T6103 | VS-5584 | SB2343,VS 5584,VS5584 | PI3K , mTOR |
VS-5584 (SB2343) is a pan-PI3K/mTOR kinase inhibitor. | |||
T2706 | Palomid 529 | P529,SG 00529 | Apoptosis , mTOR |
Palomid 529 (SG 00529) has been used in trials studying the treatment of Age-Related Macular Degeneration. | |||
T6030 | XL388 | P450 , PI3K , mTOR | |
XL388 is a highly effective, specifc, ATP-competitive inhibitor of mTOR ( IC50: 9.9 nM), 1000-fold selectivity than the closely related PI3K kinases. | |||
T1859 | AZD-8055 | Apoptosis , mTOR , Autophagy | |
AZD8055 is an ATP-competitive mTOR inhibitor (IC50: 0.8 nM in MDA-MB-468 cells). It is ~1,000-fold selective for mTOR over all PI3K isoforms. | |||
T1970 | Gedatolisib | PF-05212384,PKI-587 | PI3K , mTOR |
Gedatolisib (PF-05212384) is a highly effective dual inhibitor targeting the PI3Kα/γ (IC50: 0.4/5.4 nM)and mTOR (IC50: 1.6 nM) in the PI3K/mTOR signaling pathway. | |||
T6510 | GDC-0349 | RG-7603 | PI3K , mTOR , Autophagy |
GDC-0349 (RG-7603) is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 3.8 nM, 790-fold inhibitory effect against PI3Kα and other 266 kinases. Phase 1. | |||
T7014 | Voxtalisib | XL765,SAR245409 | DNA-PK , PI3K , mTOR |
Voxtalisib (XL765) (SAR245409, XL765) is a dual inhibitor of mTOR/PI3K, mostly for p110γ with IC50 of 9 nM; also inhibits DNA-PK and mTOR. Phase 1/2. | |||
T2235 | Dactolisib | BEZ235,NVP-BEZ235 | ATM/ATR , PI3K , mTOR , Autophagy |
Dactolisib (BEZ235) is an orally bioavailable inhibitor of PI3K and mTOR (IC50s: 4 nM/5 nM/7 nM/75 nM, and 20.7 nM for p110α/p110γ/p110δ/p110β and mTOR). | |||
T6143 | PI-103 | PI103,PI 103 | Apoptosis , DNA-PK , PI3K , mTOR , Autophagy |
PI-103 is a potent, cell-permeable, ATP-competitive inhibitor of PI3K family members (IC50s: 2/3/3/15/30/23 nM for p110α/β/δ/γ, mTOR, and DNA-PK). | |||
T6346 | WYE-132 | WYE 125132,WYE125132,WYE-125132 | Apoptosis , mTOR |
WYE-125132 (WYE-132 (WYE-125132)) is a highly potent, ATP-competitive mTOR inhibitor with IC50 of 0.19 nM; highly selective for mTOR versus PI3Ks or PI3K-related kinases hSMG1 and ATR. | |||
T3351 | Onatasertib | CC223,CC 223,CC-223 | Apoptosis , c-Fms , DNA-PK , FLT , PI3K , mTOR |
Onatasertib (CC223) is an orally available mTOR inhibitor with potential antitumor activity. Onatasertib inhibits the activity of mTOR, which may result in the induction of tumor cell apoptosis and a decrease in tumor ce... | |||
T2265 | Bimiralisib | 5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine,PQR309,PI3K-IN-2 | Others , PI3K , S6 Kinase , mTOR |
Bimiralisib (PI3K-IN-2) is an orally bioavailable pan inhibitor of PI3K and inhibitor of the mTOR, with potential antineoplastic activity. PI3K-IN-2 inhibits the PI3K kinase isoforms alpha, beta, gamma and delta and, to ... | |||
T28439 | PP30 | PP 30,PP-30 | |
PP30 is an inhibitor of mTORC1 and mTORC2. It is selective within the PI3K family, inhibiting other PI3Ks only at high concentrations. | |||
T11328 | FT-1518 | mTOR | |
T21816 | OXA-01 | ||
OXA-01 is a potent mTORC1 and mTORC2 inhibitor, with IC 50 values of 29 nM and 7 nM, respectively [1]. OXA-01 demonstrates broad anti-tumor activity. | |||
T31223 | DCBCI0901 | DCBCI-0901,DCBCI 0901 | |
DCBCI0901 is an inhibitor of phosphatidylinositide 3-kinase (PI3K), raptor-mTOR (mTOR complex 1 or mTORC1) and rictor-mTOR (mTOR complex 2 or mTORC2) with potential antineoplastic activity. | |||
T61505 | CC-115 hydrochloride | ||
CC-115 hydrochloride is a potent dual inhibitor of DNA-PK and mTOR kinase, exhibiting IC50 values of 13 nM and 21 nM, respectively. It effectively blocks both mTORC1 and mTORC2 signaling pathways. | |||
T30441 | BI-860585 | BI860585 | |
BI-860585 is an inhibitor of Raptor-Mammalian Target of Rapamycin (mTOR) Complex 1 (mTOR Complex 1; mTORC1) and rictor-mTOR Complex 2 (mTOR Complex 2; mTORC2), with potential Anti-tumor activity. | |||
T61659 | CC214-2 | ||
CC214-2 is a potent dual inhibitor of mTORC1 and mTORC2, known for its ability to impede autophagy by modulating mammalian target of rapamycin (mTOR) signaling. With this capacity, CC214-2 shows promise in shortening the... | |||
T39959 | RMC-6272 | RM-006,RMC-6272 | |
RMC-6272 (RM-006) is a bi-steric inhibitor that selectively targets mTORC1, displaying potent and selective (> 10-fold) inhibition over mTORC2. Compared to Rapamycin, RMC-6272 demonstrates enhanced inhibition of mTORC1 a... | |||
T39958 | (32-Carbonyl)-RMC-5552 | ||
(32-Carbonyl)-RMC-5552 is a highly effective mTOR inhibitor, exhibiting inhibitory effects on both mTORC1 and mTORC2 substrate phosphorylation. Specifically, it significantly suppresses the phosphorylation of p-P70S6K-(T... | |||
T72270 | WYE-687 dihydrochloride | ||
WYE-687 dihydrochloride is an ATP-competitive inhibitor of mTOR, demonstrating potent activity with an IC 50 value of 7 nM. It effectively suppresses the activation of both mTORC1 and mTORC2. Additionally, WYE-687 exhibi... | |||
T6143L | PI-103 Hydrochloride | ||
PI-103 Hydrochloride is a potent dual inhibitor of PI3K and mTOR, demonstrating inhibitory IC50 values of 8 nM for p110α, 88 nM for p110β, 48 nM for p110δ, 150 nM for p110γ, 20 nM for mTORC1, and 83 nM for mTORC2, respec... | |||
T80546 | Thioether-cyclized helix B peptide, CHBP | mTOR | |
Thioether-cyclized helix B peptide (CHBP) enhances metabolic stability and exerts renoprotective effects by promoting autophagy through the inhibition of mTOR C1 and activation of mTOR C2 [1]. | |||
T80547 | Thioether-cyclized helix B peptide, CHBP TFA | mTOR | |
Thioether-cyclized helix B peptide, CHBP (TFA), is the trifluoroacetic (TFA) salt of CHBP. This form enhances metabolic stability and exhibits renoprotective effects by promoting autophagy, achieved through the inhibitio... |
カタログ番号 | 製品名 | Species | Expression System |
---|---|---|---|
TMPY-06815 | SYAP1 Protein, Human, Recombinant (His) | Human | Baculovirus Insect Cells |
Synapse-associated protein 1 (SYAP1), also known as PRO3113 and BSTA, belongs to the synapse-associated BSD domain family, featuring three α-helices and two conserved tryptophan and phenylalanine residues located at the ... | |||
TMPH-02526 | Arginase-2/ARG2 Protein, Mouse, Recombinant (His & SUMO) | Mouse | E. coli |
May play a role in the regulation of extra-urea cycle arginine metabolism and also in down-regulation of nitric oxide synthesis. Extrahepatic arginase functions to regulate L-arginine bioavailability to nitric oxid synth... |